These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 553798)
1. [Adjuvant colchicine pharmaceuticals in the combined surgical treatment of breast cancer (author's transl)]. Li SL; Liu L; Ma SZ; Li YY; Ning LS Zhonghua Zhong Liu Za Zhi; 1979; 1(3):212-5. PubMed ID: 553798 [No Abstract] [Full Text] [Related]
2. 5 year results in 90 cases of breast cancer following combined treatment with colchicine derivatives, mastectomy and postoperative radiotherapy. Chin Med J (Engl); 1980 Apr; 93(4):227-30. PubMed ID: 6768522 [No Abstract] [Full Text] [Related]
3. [Remarks on surgical anatomy of the breast in relation to tumor pathology (author's transl)]. Berta V; Perelli Ercolini M; Beani G Chir Ital; 1980 Feb; 32(1):166-72. PubMed ID: 7448965 [TBL] [Abstract][Full Text] [Related]
4. Postoperative loco-regional radiation therapy for breast cancer patients with four or more involved lymph nodes or extracapsular extension. Evron E; Barzily L; Rakowsky E; Ben-Baruch N; Sulkes J; Rizel S; Fenig E Isr Med Assoc J; 2005 Jul; 7(7):439-42. PubMed ID: 16011059 [TBL] [Abstract][Full Text] [Related]
5. One more change of paradigm in breast cancer treatment. Postmastectomy radiotherapy for patients with one to three lymph node metastases? Sautter-Bihl ML; Sauer R Strahlenther Onkol; 2007 Jul; 183(7):357-9. PubMed ID: 17609867 [No Abstract] [Full Text] [Related]
6. Systemic adjuvant therapy in treatment of primary operable breast cancer: National Surgical Adjuvant Breast and Bowel Project experience. Fisher B; Redmond C; Fisher ER; Wolmark N NCI Monogr; 1986; (1):35-43. PubMed ID: 3534589 [TBL] [Abstract][Full Text] [Related]
7. Treatment trends and factors associated with survival in T1aN0 and T1bN0 breast cancer patients. Kennedy T; Stewart AK; Bilimoria KY; Patel-Parekh L; Sener SF; Winchester DP Ann Surg Oncol; 2007 Oct; 14(10):2918-27. PubMed ID: 17638060 [TBL] [Abstract][Full Text] [Related]
8. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting]. Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231 [TBL] [Abstract][Full Text] [Related]
9. The role of adjuvant therapy in the management of node negative breast cancer. Young V; O'Connell PR; Keane FB Ir Med J; 1990 Mar; 83(1):34-5. PubMed ID: 2361839 [No Abstract] [Full Text] [Related]
10. [The treatment of carcinoma in situ of the breast (author's transl)]. Börner P; Heidenreich W; Majewski A Geburtshilfe Frauenheilkd; 1975 Nov; 35(11):837-45. PubMed ID: 1193354 [TBL] [Abstract][Full Text] [Related]
11. Treatment of breast cancer. Zurrida S; Veronesi U Ann Chir Gynaecol; 2000; 89(3):187-90. PubMed ID: 11079786 [No Abstract] [Full Text] [Related]
12. Weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients. Alliot C J Clin Oncol; 2005 Jun; 23(18):4237-8; author reply 4238-9. PubMed ID: 15961776 [No Abstract] [Full Text] [Related]
13. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. Ragaz J; Olivotto IA; Spinelli JJ; Phillips N; Jackson SM; Wilson KS; Knowling MA; Coppin CM; Weir L; Gelmon K; Le N; Durand R; Coldman AJ; Manji M J Natl Cancer Inst; 2005 Jan; 97(2):116-26. PubMed ID: 15657341 [TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node biopsy for breast cancer: indications, contraindications, and new directions. Cody HS J Surg Oncol; 2007 May; 95(6):440-2. PubMed ID: 17458860 [No Abstract] [Full Text] [Related]
15. [Clinical analysis of resectable breast cancer: a report of 6 263 cases]. Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535 [TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study. Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501 [TBL] [Abstract][Full Text] [Related]
17. Re: Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. Kunkler I J Natl Cancer Inst; 2005 Aug; 97(15):1162-3; author reply 1163-4. PubMed ID: 16077078 [No Abstract] [Full Text] [Related]
18. Breast conservation after neoadjuvant chemotherapy for stage II carcinoma of the breast. Schwartz GF; Meltzer AJ; Lucarelli EA; Cantor JP; Curcillo PG J Am Coll Surg; 2005 Sep; 201(3):327-34. PubMed ID: 16125064 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of breast carcinoma. Results of telecobaltherapy associated to surgery (author's transl)]. Dana M; Koskas-Uhry A; Koskas Y Nouv Presse Med; 1978 Dec; 7(45):4115-8. PubMed ID: 745940 [TBL] [Abstract][Full Text] [Related]
20. Expanding the indications for sentinel lymph node surgery in breast cancer. Boughey JC; Hunt KK Future Oncol; 2007 Feb; 3(1):9-14. PubMed ID: 17280496 [No Abstract] [Full Text] [Related] [Next] [New Search]